163 related articles for article (PubMed ID: 3728269)
1. Discordance between ambulatory monitoring and programmed stimulation in assessing efficacy of mexiletine in patients with ventricular tachycardia.
Kim SG; Seiden SW; Matos JA; Waspe LE; Fisher JD
Am Heart J; 1986 Jul; 112(1):14-9. PubMed ID: 3728269
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiologic effects and clinical efficacy of mexiletine used alone or in combination with class IA agents for refractory recurrent ventricular tachycardias or ventricular fibrillation.
Kim SG; Felder SD; Waspe LE; Fisher JD
Am J Cardiol; 1986 Sep; 58(6):485-90. PubMed ID: 3529910
[TBL] [Abstract][Full Text] [Related]
3. Discordance between ambulatory monitoring and programmed stimulation in assessing efficacy of class IA antiarrhythmic agents in patients with ventricular tachycardia.
Kim SG; Seiden SW; Matos JA; Waspe LE; Fisher JD
J Am Coll Cardiol; 1985 Sep; 6(3):539-44. PubMed ID: 2411776
[TBL] [Abstract][Full Text] [Related]
4. Comparison of programmed stimulation and Holter monitoring for predicting long-term efficacy and inefficacy of amiodarone used alone or in combination with a class 1A antiarrhythmic agent in patients with ventricular tachyarrhythmia.
Kim SG; Felder SD; Figura I; Johnston DR; Waspe LE; Fisher JD
J Am Coll Cardiol; 1987 Feb; 9(2):398-404. PubMed ID: 3805529
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of the changes in the mode of ventricular tachycardia induction noted during therapy with a marked reduction of ventricular ectopic activity.
Kim SG; Felder SD; Seiden SW; Waspe LE; Fisher JD
Am Heart J; 1987 Nov; 114(5):1138-45. PubMed ID: 3673880
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the characteristics of nonsustained ventricular tachycardia on Holter monitoring and sustained ventricular tachycardia observed spontaneously or induced by programmed stimulation.
Kim SG; Mercando AD; Fisher JD
Am J Cardiol; 1987 Aug; 60(4):288-92. PubMed ID: 3618487
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the antiarrhythmic efficacy of disopyramide and mexiletine against stimulus-induced ventricular tachycardia.
Breithardt G; Seipel L; Abendroth RR
J Cardiovasc Pharmacol; 1981; 3(5):1026-37. PubMed ID: 6168848
[TBL] [Abstract][Full Text] [Related]
8. Value of Holter monitoring in predicting long-term efficacy and inefficacy of amiodarone used alone and in combination with class 1A antiarrhythmic agents in patients with ventricular tachycardia.
Kim SG; Felder SD; Figura I; Johnston DR; Waspe LE; Fisher JD
J Am Coll Cardiol; 1987 Jan; 9(1):169-74. PubMed ID: 3794093
[TBL] [Abstract][Full Text] [Related]
9. Reproducibility of programmed electrical stimulation responses in patients with ventricular tachycardia or fibrillation associated with coronary artery disease.
Volgman AS; Zheutlin TA; Mattioni TA; Parker MA; Kehoe RF
Am J Cardiol; 1992 Sep; 70(7):758-63. PubMed ID: 1519526
[TBL] [Abstract][Full Text] [Related]
10. Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia.
Platia EV; Estes M; Heine DL; Griffith LS; Garan H; Ruskin JN; Reid PR
Am J Cardiol; 1985 Apr; 55(8):956-62. PubMed ID: 3984883
[TBL] [Abstract][Full Text] [Related]
11. Mexiletine for control of drug-resistant ventricular tachycardia: clinical and electrophysiologic results in 44 patients.
Waspe LE; Waxman HL; Buxton AE; Josephson ME
Am J Cardiol; 1983 Apr; 51(7):1175-81. PubMed ID: 6340451
[TBL] [Abstract][Full Text] [Related]
12. Intolerance and ineffectiveness of mexiletine in patients with serious ventricular arrhythmias.
Poole JE; Werner JA; Bardy GH; Graham EL; Pulaski WP; Fahrenbruch CE; Greene HL
Am Heart J; 1986 Aug; 112(2):322-6. PubMed ID: 3739884
[TBL] [Abstract][Full Text] [Related]
13. Values and limitations of programmed stimulation and ambulatory monitoring in the management of ventricular tachycardia.
Kim SG
Am J Cardiol; 1988 Nov; 62(14):7I-12I. PubMed ID: 2461072
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of malignant ventricular tachyarrhythmia with amiodarone: comparison of empirical administration and administration guided by Holter or ventricular stimulation. Results of the parallel test].
Raviele A; Di Pede F; Gasparini G; Zanocco A; Delise P; Bonso A; D'Este D; Piccolo E
G Ital Cardiol; 1991 Mar; 21(3):259-69. PubMed ID: 1894120
[TBL] [Abstract][Full Text] [Related]
15. [Clinical electrophysiological evaluation of mexiletine].
Molina L; Colín L; Micheletti T; Blank S; Camacho J
Arch Inst Cardiol Mex; 1986; 56(3):219-23. PubMed ID: 2944491
[TBL] [Abstract][Full Text] [Related]
16. Mexiletine and tocainide: does response to one predict response to the other?
Hession M; Blum R; Podrid PJ; Lampert S; Stein J; Lown B
J Am Coll Cardiol; 1986 Feb; 7(2):338-43. PubMed ID: 3080508
[TBL] [Abstract][Full Text] [Related]
17. Mexiletine for recurring ventricular arrhythmias: assessment by long-term electrocardiographic recordings and sequential electrophysiologic studies.
Flaker GC; Madigan NP; Alpert MA; Moser SA
Am Heart J; 1984 Sep; 108(3 Pt 1):490-5. PubMed ID: 6475711
[TBL] [Abstract][Full Text] [Related]
18. The use of ambulatory monitoring in the prognostic evaluation of patients with sustained ventricular tachycardia treated with amiodarone.
Veltri EP; Griffith LS; Platia EV; Guarnieri T; Reid PR
Circulation; 1986 Nov; 74(5):1054-60. PubMed ID: 3769165
[TBL] [Abstract][Full Text] [Related]
19. Programmed electrical stimulation and long-term follow-up in asymptomatic, nonsustained ventricular tachycardia.
Veltri EP; Platia EV; Griffith LS; Reid PR
Am J Cardiol; 1985 Aug; 56(4):309-14. PubMed ID: 4025171
[TBL] [Abstract][Full Text] [Related]
20. [Mexiletine treatment of ventricular tachy-arrhythmias endangering life based on programmed ventricular stimulation].
Møller M; Love J; Haffajee C; Sloan K; Alpert J
Ugeskr Laeger; 1985 Apr; 147(15):1254-7. PubMed ID: 4002389
[No Abstract] [Full Text] [Related]
[Next] [New Search]
